Kelsie L. Thu

Dikutip oleh

	Semua	Sejak 2020
Kutipan	5305	2932
indeks-h	39	30
indeks-i10	54	46

680

340

170

510

201020112012201320142015201620172018201920202021202220232024202522 37 49 126 167 211 328 371 482 546 585 671 548 530 511 87

Akses publik

Lihat semua

55 artikel

2 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Wan L. LamBC Cancer Research Centre; University of British ColumbiaEmail yang diverifikasi di bccrc.ca
Emily Ann VucicNYU Langone Medical CenterEmail yang diverifikasi di nyulangone.org
Adi GazdarProfessor of Pathology, UT Southwestern Medical CenterEmail yang diverifikasi di utsouthwestern.edu
Raj ChariLeidos Biomedical Research, Frederick National Lab for Cancer ResearchEmail yang diverifikasi di nih.gov
William LockwoodDistinguished Scientist, British Columbia Cancer Agency - Professor, University of British ColumbiaEmail yang diverifikasi di bccrc.ca
David W. CesconMedical Oncologist and Clinician Scientist, Princess Margaret Cancer Centre, University of TorontoEmail yang diverifikasi di uhn.ca
Victor D MartinezClinical Genomics Specialist, IWK Health Centre | Assistant Professor, Dalhousie UniversityEmail yang diverifikasi di iwk.nshealth.ca
Ming TsaoUniversity of Toronto, University Health Network, Princess Margaret Cancer CentreEmail yang diverifikasi di uhn.ca
Bradley P CoeLaboratory Scientist, BC Children's and Women's HospitalEmail yang diverifikasi di cw.bc.ca
Daiana Becker-Santos, PhDBC Cancer Research CentreEmail yang diverifikasi di bccrc.ca
Junichi SohOsaka Metropolitan UniversityEmail yang diverifikasi di omu.ac.jp
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkEmail yang diverifikasi di uhnresearch.ca
Katey SS EnfieldUniversity of British Columbia, BC Cancer Research InstituteEmail yang diverifikasi di bccrc.ca
John MinnaProfessor of Internal Medicine and Pharmacology, University of Texas Southwestern Medical CenterEmail yang diverifikasi di utsouthwestern.edu
Carolyn J. BrownProfessor, Medical Genetics, Life Sciences Institute, University of British ColumbiaEmail yang diverifikasi di ubc.ca
Zhaleh SafikhaniPost doctoral fellowEmail yang diverifikasi di utoronto.ca
Igor JurisicaEmail yang diverifikasi di ai.utoronto.ca
Carlos E. Alvarez, PhDPediatrics & Veterinary Clinical Sciences, The Ohio State University Colleges of Med. & Vet. Med.Email yang diverifikasi di osu.edu

Ikuti

Kelsie L. Thu

St. Michael's Hospital

Email yang diverifikasi di unityhealth.to - Beranda

Lung Cancer Drug Response Functional Genomics


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours H Xu, M Di Antonio, S McKinney, V Mathew, B Ho, NJ O’Neil, ND Santos, ... Nature communications 8 (1), 14432, 2017	545	2017
Targeting mitosis in cancer: emerging strategies C Dominguez-Brauer, KL Thu, JM Mason, H Blaser, MR Bray, TW Mak Molecular cell 60 (4), 524-536, 2015	517	2015
Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell–like properties in cancer cells K Shien, S Toyooka, H Yamamoto, J Soh, M Jida, KL Thu, S Hashida, ... Cancer research 73 (10), 3051-3061, 2013	303	2013
The detection and implication of genome instability in cancer L Pikor, K Thu, E Vucic, W Lam Cancer and Metastasis Reviews 32, 341-352, 2013	243	2013
Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2 S Inoue, WY Li, A Tseng, I Beerman, AJ Elia, SC Bendall, F Lemonnier, ... Cancer cell 30 (2), 337-348, 2016	226	2016
Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology VD Martinez, EA Vucic, KL Thu, R Hubaux, KSS Enfield, LA Pikor, ... Scientific reports 5 (1), 10423, 2015	188	2015
Targeting the cell cycle in breast cancer: towards the next phase KL Thu, I Soria-Bretones, TW Mak, DW Cescon Cell Cycle 17 (15), 1871-1885, 2018	179	2018
DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways EA Vucic, R Chari, KL Thu, IM Wilson, AM Cotton, JY Kennett, M Zhang, ... American journal of respiratory cell and molecular biology 50 (5), 912-922, 2014	162	2014
Polycomb-mediated silencing in neuroendocrine prostate cancer PL Clermont, D Lin, F Crea, R Wu, H Xue, Y Wang, KL Thu, WL Lam, ... Clinical epigenetics 7, 1-13, 2015	150	2015
Translating cancer ‘omics’ to improved outcomes EA Vucic, KL Thu, K Robison, LA Rybaczyk, R Chari, CE Alvarez, WL Lam Genome research 22 (2), 188-195, 2012	148	2012
Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma WW Lockwood, R Chari, BP Coe, KL Thu, C Garnis, CA Malloff, ... PLoS medicine 7 (7), e1000315, 2010	133	2010
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non–small-cell lung cancer KW Tam, W Zhang, J Soh, V Stastny, M Chen, H Sun, K Thu, JJ Rios, ... Journal of thoracic oncology 8 (11), 1378-1388, 2013	115	2013
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer SP Kubli, C Bassi, C Roux, A Wakeham, C Göbl, W Zhou, SM Jafari, ... Proceedings of the National Academy of Sciences 116 (9), 3604-3613, 2019	108	2019
Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer BP Coe, KL Thu, S Aviel-Ronen, EA Vucic, AF Gazdar, S Lam, MS Tsao, ... PloS one 8 (8), e71670, 2013	103	2013
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer SD Bailey, K Desai, KJ Kron, P Mazrooei, NA Sinnott-Armstrong, ... Nature genetics 48 (10), 1260-1266, 2016	102	2016
EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation R Hubaux, KL Thu, BP Coe, C MacAulay, S Lam, WL Lam Journal of Thoracic Oncology 8 (8), 1102-1106, 2013	100	2013
Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role PL Clermont, L Sun, F Crea, KL Thu, A Zhang, A Parolia, WL Lam, ... British journal of cancer 111 (8), 1663-1672, 2014	96	2014
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer PL Clermont, F Crea, YT Chiang, D Lin, A Zhang, JZL Wang, A Parolia, ... Clinical epigenetics 8, 1-14, 2016	89	2016
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers M Kawakami, LM Mustachio, L Zheng, Y Chen, J Rodriguez-Canales, ... Proceedings of the National Academy of Sciences 115 (8), 1913-1918, 2018	87	2018
Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer KL Thu, J Silvester, MJ Elliott, W Ba-Alawi, MH Duncan, AC Elia, AS Mer, ... Proceedings of the National Academy of Sciences 115 (7), E1570-E1577, 2018	84	2018

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama